galactosamine has been researched along with suramin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, A; Goto, T; Kataoka, E; Mikami, K; Miura, K; Ohshima, S; Sato, M; Sato, W; Segawa, D; Shibuya, T; Takeuchi, S; Watanabe, D; Watanabe, S; Yoneyama, K; Yoshino, R | 1 |
1 other study(ies) available for galactosamine and suramin
Article | Year |
---|---|
Suramin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of NF-kappaB activity.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cell Line; Cytokines; Galactosamine; Interleukin-6; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Suramin; Survival Rate; Tumor Necrosis Factor-alpha | 2006 |